Fabino Life Sciences IPO Details, GMP Price, Allotment Status, Review |Fabino Life Sciences IPO Subscription Status

Fabino Life Sciences IPO, Fabino Life Sciences IPO GMP, Fabino Life Sciences GMP, Fabino Life Sciences IPO GMP TODAY, Fabino Life Sciences IPO REVIEW, Fabino Life Sciences IPO DETAILS

Fabino Life Sciences IPO will open on 31 December 2021 and will close on 05 Jan 2022.

Fabino life sciences Limited is one of the growing pharmaceutical companies. This company is located near the New Delhi NCR region of India. The company understands the Healthcare requirement and offers the top quality products to meet the specific needs of its customers. This company emphasizes developing high-quality and affordable products for all sections of the society that is to provide the best quality products for the good health and well-being of the people.

 Their mission is customer satisfaction and to achieve the leadership in the market they are.  They are in various categories like allopathic products, covid-19 products, food supplement products, and multivitamin products. 

Fabino Life Sciences IPO
Fabino Life Sciences IPO Details, GMP Price, Allotment Status, Review, and Other Details, Apply Now

Fabino Life Sciences IPO will open on 31 December 2021 and will close on 05 Jan 2022. The price band is fixed at 33-35 Rupees per share and a lot of shares is 4000. They are going to be listed on BSE SME and going to raise 10.09 crore rupees.

Fabino Life Sciences IPO Subscription Status (Live Data – Day 3)

CategoryDay 1Day 2Day 3
NII0.791.691.69
RII0.783.613.61
Total0.792.652.65
Fabino Life Sciences IPO Subscription Status

Fabino Life Sciences IPO Details

DescriptionFabino Life Sciences IPO Details
Public Issue900,000 Eq Shares of ₹10 (aggregating up to ₹3.24 Cr)
Issue Open  Date31-Dec-21
Issue Close Date05-Jan-22
IPO Price Band₹ 36
Face Value â‚¹ 10
Market Lot 3000 Equity Shares and in multiples thereof
Minimum Order Quantity 3000 Equity Shares
Listing BSE SME
Fabino Life Sciences IPO Details

Fabino Life Sciences Financials

ParticularsFor the year/period ended (₹ in Millions)
 30-Jun-2131-Mar-2131-Mar-2031-Mar-19
Total Assets28.1422.5135.8885.53
Total Revenue11.2930.5975.1627.61
Profit After Tax0.140.300.680.001
Fabino Life Sciences IPO Financials

Fabino Life Sciences IPO Promoter Holding

Pre Issue Share Holding99.43%
Post Issue Share Holding56.82%
Fabino Life Sciences IPO

Fabino Life Sciences IPO Important Dates

Offer start2021-12-31
Offer end2022-01-05
Allotment finalisation2022-01-10
Refund initiation 2022-01-11
Demat transfer2022-01-12
Listing2022-01-13
Fabino Life Sciences IPO Important Dates

Company Promoters

Atul Kumar Jain is the company’s promoter.

Fabino Life Sciences IPO Registrar

Bigshare Services Pvt Ltd

Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: http://www.bigshareonline.com

Fabino Life Sciences Company Address

Fabino Life Sciences Limited
105, 1st Floor, Barodia Tower, Plot No 12,
D Block Central Market Prashant Vihar,
New Delhi 110085
Phone: +91-9883900021
Email: info@fabinolife.com
Website: https://www.fabinolife.com/

How to Apply Fabino Life Sciences IPO?

You can signup or log in to Zerodha and apply there.

Also Check Upcoming IPO watch list

What is Fabino Life Sciences IPO?

Fabino Life Sciences IPO will open on 31 December 2021 and will close on 05 Jan 2022. The price band is fixed at 33-35 Rupees per share and a lot of shares is 4000.

When Fabino Life Sciences IPO will open?

Fabino Life Sciences IPO will open on 31 December 2021.

When Fabino Life Sciences IPO will close?

Fabino Life Sciences IPO will close on 05 January 2022.

How To Apply in Fabino Life Sciences IPO?

Below are the steps to apply for Fabino Life Sciences IPO .
1. First of all, Visit the Zerodha website and log in to Console.
2. Then you need to go to Portfolio and click the IPOs link.
3. Go to the ‘Fabino Life Sciences IPO’ row and then click on the ‘Bid’ button.
4. Enter your UPI ID, Quantity, and Price.
5. After that, ‘Submit the’ IPO application form.
6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Leave a Comment